The Red Sox announced on Monday that starter Chris Sale saw Dr. James Andrews, who confirmed the lefty is dealing with inflammation in his pitching elbow. Sale received a platelet-rich plasma injection and has been shut down from throwing. He will be reevaluated in six weeks.
Six weeks takes us to the day after the end of the regular season, so Sale is effectively done for the year. The Red Sox are 16.0 games out of first place in the AL East, but are 6.5 games out of the second Wild Card. Even if the Red Sox got into the playoffs as a Wild Card, Sale would need to build his stamina back up so he likely wouldn’t be available in the ALDS at the very least.
Sale, 30, went 6-11 with a 4.40 ERA and a 218/37 K/BB ratio in 147 1/3 innings across 25 starts this year. His five-year, $145 million contract extension will begin next year.
Phillies outfielder Andrew McCutchen would have opened the regular season on the injured list if it had started on time. Now, with the start of the season pushed back at least a few months due to coronavirus (COVID-19), the veteran five-time All-Star says he will be “ready to go” whenever the season begins, he told NBC Sports Philadelphia.
McCutchen, 33, tore his ACL in early June, ending his 2019 campaign. To that point, he had been quite productive for the Phillies, batting .256/.378/.457 with 10 home runs and 29 RBI over 262 plate appearances. If and when the 2020 season does begin, he will likely reprise his role as the leadoff hitter, this time under new manager Joe Girardi.
2020 marks the second year of McCutchen’s three-year, $50 million contract initially signed with the Phillies in December 2018. The Phillies also hold a $15 million club option for the 2022 season with a $3 million buyout.